Abstract | BACKGROUND: Percutaneous transhepatic portal embolization (PTPE) can induce atrophy of the embolized- and hypertrophy of the residual area. These effects are advantageous in patients scheduled for extended hepatectomy. PURPOSE: MATERIAL AND METHODS: We performed sclerotherapy for PTPE in 15 patients with: hepatocellular carcinoma (HHC; n = 9), bile duct carcinoma (n = 5), or metastatic liver tumor from colon cancer (n = 1). The foam contained 5% EO iopamidol (EOI) and CO2 at a 1:2 ratio. We compared the percentage of the pre- and post-PTPE future liver remnant (FLR) volumes and calculated the percent FLR volume (%FLR) increase after PTPE. RESULTS: The amount of EOI used (range, 14-20 mL; median, 16.8 mL) was based on the volume of the target portal vein. Technical success was achieved in 14 of 15 patients (93%); the other patient presented with computed tomography evidence of recanalization 1 week after PTPE. The FLR volume before and after portal vein embolization was 599 ± 342 and 691 ± 318 cm(3), respectively (P < 0.01); the mean %FLR volume increase was 29.5%. There was no significant difference in the mean platelet count, total bilirubin, total aspartate aminotransferase, and total creatinine before and after PTPE. One patient suffered intra-abdominal bleeding that required transcatheter arterial embolization. No other patients developed major complications higher than grade 3. CONCLUSION:
|
Authors | Seijiro Inoue, Osamu Ikeda, Yutaka Nakasone, Toru Beppu, Toshiro Masuda, Koichi Yokoyama, Daisuke Utsunomiya, Hideo Baba, Yasuyuki Yamashita |
Journal | Acta radiologica (Stockholm, Sweden : 1987)
(Acta Radiol)
Vol. 56
Issue 11
Pg. 1361-7
(Nov 2015)
ISSN: 1600-0455 [Electronic] England |
PMID | 26113740
(Publication Type: Journal Article)
|
Copyright | © The Foundation Acta Radiologica 2015. |
Chemical References |
- Oleic Acids
- Sclerosing Solutions
- Carbon Dioxide
- ethanolamine oleate
|
Topics |
- Aged
- Aged, 80 and over
- Angiography, Digital Subtraction
- Balloon Occlusion
- Bile Duct Neoplasms
(diagnostic imaging, therapy)
- Carbon Dioxide
(therapeutic use)
- Carcinoma, Hepatocellular
(diagnostic imaging, therapy)
- Embolization, Therapeutic
(methods)
- Female
- Hepatectomy
- Humans
- Liver Function Tests
- Liver Neoplasms
(diagnostic imaging, therapy)
- Male
- Middle Aged
- Oleic Acids
(therapeutic use)
- Pilot Projects
- Portal Vein
- Retrospective Studies
- Sclerosing Solutions
(therapeutic use)
- Tomography, X-Ray Computed
- Treatment Outcome
|